Article
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs.
Nature medicine - 1 Sept 1999
Schuetz J D, Connelly M C, Sun D, Paibir S G, Flynn P M, Srinivas R V, Kumar A, Fridland A
Abstract excerpt
Dideoxynucleosides, which are potent inhibitors of HIV reverse transcriptase and other viral DNA polymerases, are a common component of highly active anti-retroviral therapy (HAART) (ref. 1). Six reverse transcriptase inhibitors have been approved for human use: azidothymidine; 2'3'-dideoxycytidine; 2'3'-dideoxyinosine; 2', 3'-didehydro-3'deoxythymidine; 2',3'-dideoxy-3'-thiacytidine; and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
